• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例卡介苗(BCG)膀胱灌注治疗1个月后发生播散性卡介苗病及2017 - 2022年日本77例疑似卡介苗感染病例分析

A case of disseminated bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017-2022.

作者信息

Nishimura Masashi, Okumura Masao, Takemasa Takii, Yoshiyama Takashi, Tanaka Yoshiaki, Saotome Mikio, Ohta Ken

机构信息

Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.

Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Japan.

出版信息

Respir Med Case Rep. 2023 Jul 22;45:101902. doi: 10.1016/j.rmcr.2023.101902. eCollection 2023.

DOI:10.1016/j.rmcr.2023.101902
PMID:37538979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10393993/
Abstract

Bacillus Calmette-Guerin (BCG) intravesical injections are used as adjuvant therapy for superficial bladder cancer. We report a case of a 78-year-old man who developed disseminated BCG disease mimicking miliary tuberculosis early after BCG intravesical infusion. He started coughing after receiving three rounds of BCG for superficial bladder tumors, following transurethral resection of the tumors, approximately one month after initiation. Computerized tomography (CT) images showed diffuse nodular shadows in the bilateral lung fields with a random pattern. Consequently, disseminated BCG disease was diagnosed. Treatment with isoniazid, rifampicin, and ethambutol was initiated. Nine months after initiating treatment, CT showed the disappearance of the miliary shadows. We also discussed 77 cases of suspected BCG infection and the requests for BCG identification at our institution from 2017 to October 2022. Of these, 76 cases were BCG, and 1 case was Since can be identified in some patients with suspected BCG infection, it is crucial to distinguish between the two based on pathogenicity.

摘要

卡介苗(BCG)膀胱内注射用作浅表性膀胱癌的辅助治疗。我们报告一例78岁男性,在卡介苗膀胱内灌注后早期出现类似粟粒性肺结核的播散性卡介苗病。在经尿道肿瘤切除术后,他在接受三轮卡介苗治疗浅表膀胱肿瘤后约1个月开始咳嗽,最初是因为浅表膀胱肿瘤。计算机断层扫描(CT)图像显示双肺野弥漫性结节状阴影,呈随机分布。因此,诊断为播散性卡介苗病。开始使用异烟肼、利福平及乙胺丁醇治疗。治疗9个月后,CT显示粟粒状阴影消失。我们还讨论了2017年至2022年10月在我们机构的77例疑似卡介苗感染病例及卡介苗鉴定请求。其中,76例为卡介苗,1例为……由于在一些疑似卡介苗感染患者中可以鉴定出……,基于致病性区分两者至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aec/10393993/32e93d6797e2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aec/10393993/32e93d6797e2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aec/10393993/32e93d6797e2/gr1.jpg

相似文献

1
A case of disseminated bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017-2022.1例卡介苗(BCG)膀胱灌注治疗1个月后发生播散性卡介苗病及2017 - 2022年日本77例疑似卡介苗感染病例分析
Respir Med Case Rep. 2023 Jul 22;45:101902. doi: 10.1016/j.rmcr.2023.101902. eCollection 2023.
2
[Miliary Pulmonary Tuberculosis After Intravesical BCG Instillation in a Patient with High-Grade Bladder Cancer].[一名高级别膀胱癌患者膀胱内灌注卡介苗后发生粟粒性肺结核]
Mikrobiyol Bul. 2023 Oct;57(4):675-681. doi: 10.5578/mb.20239955.
3
Miliary tuberculosis following intravesical Bacillus Calmette and Guérin therapy: A rare complication of a frequent procedure.膀胱内卡介苗治疗后粟粒性肺结核:一种常见治疗方法的罕见并发症。
Urol Case Rep. 2021 Mar 26;38:101655. doi: 10.1016/j.eucr.2021.101655. eCollection 2021 Sep.
4
Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report.卡介苗膀胱内灌注治疗膀胱癌后发生分枝杆菌感染:一例报告
Korean J Lab Med. 2011 Jul;31(3):197-200. doi: 10.3343/kjlm.2011.31.3.197. Epub 2011 Jun 28.
5
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.卡介苗(BCG)膀胱内灌注作为膀胱癌辅助治疗后的感染:单中心系列研究中的发病率、危险因素及结局,并对文献进行综述
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
6
Super acute-onset disseminated BCG infection: A case report.超急性播散性卡介苗感染:一例报告。
J Infect Chemother. 2023 Sep;29(9):919-921. doi: 10.1016/j.jiac.2023.05.017. Epub 2023 May 23.
7
A case of miliary tuberculosis following transurethral surgery and prostate biopsy after intravesical Bacillus Calmette-Guerin immunotherapy.1例卡介苗膀胱内免疫治疗后经尿道手术及前列腺活检引发粟粒性肺结核的病例。
IJU Case Rep. 2021 Oct 3;5(1):45-47. doi: 10.1002/iju5.12385. eCollection 2022 Jan.
8
A case of infectious thoracic aortic aneurysm after intravesical Bacillus Calmette-Guérin instillation therapy for a superficial bladder cancer.1例浅表性膀胱癌经膀胱内卡介苗灌注治疗后发生感染性胸主动脉瘤。
Urol Case Rep. 2021 Jan 20;36:101574. doi: 10.1016/j.eucr.2021.101574. eCollection 2021 May.
9
Ruptured aortic aneurysm due to Mycobacterium bovis BCG with a delayed bacteriological diagnosis due to false negative result of the MPB 64 immunochromatographic assay.牛分枝杆菌卡介苗所致主动脉瘤破裂,因MPB 64免疫层析试验结果假阴性导致细菌学诊断延迟。
BMC Res Notes. 2017 Jan 26;10(1):64. doi: 10.1186/s13104-017-2382-6.
10
[A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].[一例在使用卡介苗(BCG)膀胱内免疫治疗膀胱癌4年后被诊断为医源性膀胱结核的病例]
Kansenshogaku Zasshi. 2016 Nov;90(6):809-13.

引用本文的文献

1
Invasive Mycobacterium bovis Infection Outside the Genitourinary Tract Following Bacille Calmette-Guerin Therapy for Non-muscle Invasive Bladder Cancer.卡介苗治疗非肌层浸润性膀胱癌后发生于泌尿生殖道外的侵袭性牛分枝杆菌感染
Cureus. 2024 Jul 1;16(7):e63613. doi: 10.7759/cureus.63613. eCollection 2024 Jul.

本文引用的文献

1
The BCG Vaccine for COVID-19: First Verdict and Future Directions.《COVID-19 用卡介苗疫苗:初步结论和未来方向》
Front Immunol. 2021 Mar 8;12:632478. doi: 10.3389/fimmu.2021.632478. eCollection 2021.
2
Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update.卡介苗(BCG)治疗膀胱癌:最新进展
Immunotargets Ther. 2020 Feb 13;9:1-11. doi: 10.2147/ITT.S202006. eCollection 2020.
3
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
卡介苗(BCG)膀胱内灌注作为膀胱癌辅助治疗后的感染:单中心系列研究中的发病率、危险因素及结局,并对文献进行综述
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
4
Sub-speciation of Mycobacterium tuberculosis complex from tuberculosis patients in Japan.从日本的结核病人中分离结核分枝杆菌复合群的亚种。
Tuberculosis (Edinb). 2014 Jan;94(1):15-9. doi: 10.1016/j.tube.2013.09.006. Epub 2013 Oct 9.
5
Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG.卡介苗(BCG)治疗中高危 Ta、T1 期膀胱乳头状癌的副作用:EORTC 泌尿生殖系统癌症组比较三分之一剂量与全剂量以及 1 年与 3 年维持 BCG 的随机 3 期研究结果。
Eur Urol. 2014 Jan;65(1):69-76. doi: 10.1016/j.eururo.2013.07.021. Epub 2013 Jul 24.
6
Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.卡介苗免疫疗法治疗泌尿生殖系统癌症。
BJU Int. 2013 Aug;112(3):288-97. doi: 10.1111/j.1464-410X.2012.11754.x. Epub 2013 Mar 20.
7
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.卡介苗免疫疗法治疗浅表性膀胱癌的免疫机制
J Urol. 2003 Sep;170(3):964-9. doi: 10.1097/01.ju.0000073852.24341.4a.
8
Mycobacterium bovis infection in human beings.人类牛分枝杆菌感染
Tuberculosis (Edinb). 2001;81(1-2):71-7. doi: 10.1054/tube.2000.0263.
9
Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.卡介苗免疫疗法在浅表性膀胱癌中的疗效与安全性
Clin Infect Dis. 2000 Sep;31 Suppl 3:S86-90. doi: 10.1086/314064.
10
Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer.膀胱癌经膀胱内卡介苗治疗后播散性牛分枝杆菌感染
Cancer Control. 2000 Sep-Oct;7(5):476-81. doi: 10.1177/107327480000700512.